Kambiz Yazdi
Stock Analyst at Jefferies
(2.47)
# 2,666
Out of 4,876 analysts
7
Total ratings
42.86%
Success rate
19.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kambiz Yazdi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVTX Avalo Therapeutics | Initiates: Buy | $23 | $4.78 | +381.17% | 1 | Mar 25, 2025 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $16 → $19 | $13.74 | +38.28% | 2 | Mar 11, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Buy | $15 | $9.64 | +55.60% | 1 | Aug 28, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $5 | $1.07 | +367.29% | 1 | Apr 12, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $75 → $128 | $43.00 | +197.67% | 2 | Mar 26, 2024 |
Avalo Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $23
Current: $4.78
Upside: +381.17%
Arcutis Biotherapeutics
Mar 11, 2025
Maintains: Buy
Price Target: $16 → $19
Current: $13.74
Upside: +38.28%
EyePoint Pharmaceuticals
Aug 28, 2024
Initiates: Buy
Price Target: $15
Current: $9.64
Upside: +55.60%
PMV Pharmaceuticals
Apr 12, 2024
Initiates: Buy
Price Target: $5
Current: $1.07
Upside: +367.29%
Praxis Precision Medicines
Mar 26, 2024
Maintains: Buy
Price Target: $75 → $128
Current: $43.00
Upside: +197.67%